We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

ESPN Survey: 2/3 of NFL Players Say Cannabis Would Cut Painkiller Use

Gage PeakePublished on November 2, 2016 · Last updated July 28, 2020
Close up of an american football on the field, players in the background

In a new ESPN survey released Wednesday, two-thirds of current NFL players say they believe their intake of chemical painkillers would be reduced if the league approved the use of medical cannabis.

Currently, cannabis is one of eight drugs banned under the NFL’s policy and program on substance abuse, despite being legal in 25 states and Washington, D.C., for medicinal purposes. Test results indicating 35 ng/mL or more of cannabis in the blood stream results in a violation, which can include fines and suspensions.

The survey was conducted by ESPN.com’s NFL Nation and ESPN The Magazine, which asked 226 players about the state of pain treatment in the league. According to ESPN, there are 1,696 players on active rosters and another 256 on practice squads.

It should be mentioned that former NFL players, including Chris Kluwe, have told Leafly that the NFL’s drug tests are fairly easy to beat.

In the ESPN survey, 61 percent of players said that if cannabis were a legal option, fewer players would take powerful pain-killing injections of drugs like Toradol. Toradol is the most common anti-inflammatory taken by players, so much so that 64 percent of the survey’s respondents said they have had at least one injection of it or another painkiller.

41 percent of players surveyed thought cannabis would control pain more effectively than Toradol, as cannabis has less known side effects than the painkiller. Of the main side effects – becoming addicted to the drug – is common in the NFL. 42 percent of the players surveyed said they’ve known a teammate who become addicted to chemical painkillers.

On adult-use legalization, the players came out strongly in favor. 71 percent of those surveyed said cannabis should be legal in the United States.

In other NFL news, former Ravens offensive lineman Eugene Monroe is featured in another ESPN story today, advocating for the use of medical cannabis in the NFL.

The longform piece is a great read, moving from Monroe’s first experience with cannabis to his present-day situation living through the aches and pains incurred during his career as a professional football player.

Monroe is now an entrepreneur working with Green Thumb Industries, which plans to open a spa-style medical marijuana dispensary in Carson City, Nevada, called Rise.

Ezekiel Elliott's Cannabis Visit Was Perfectly Normal image
Lifestyle
Ezekiel Elliott's Cannabis Visit Was Perfectly Normal
Gage Peake

Related Stories

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
footballnflsports
Gage Peake
Gage Peake
Gage Peake is a former staff writer for Leafly, where he specialized in data journalism, sports, and breaking news coverage. He's a graduate of the University of Nebraska-Lincoln's College of Journalism and Mass Communications.
View Gage Peake's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.